No health professional authorized by this subsection to conduct a body cavity search shall be held liable in any civil action if the search is conducted in a manner that meets the standards and requirements of RCW 4.24.290 and 7.70.040.
What is ibandronate (Boniva)? Ibandronate is in the group of medicines called bisphosphonates (bis FOS fo nayts). It alters the cycle of bone formation and breakdown in the body. Ibandronate slows bone loss while increasing bone mass, which may prevent bone fractures. Ibandronate is used to treat or prevent osteoporosis in women after menopause.
Reviewed by Laura J. Martin, MD. March 19, 2012 -- Three generic drugmakers may now sell their own versions of the bone-loss drug Boniva, the FDA ruled today. Boniva, known by the generic name ibandronate, is a once-a-month pill prescribed to prevent or to treat bone loss from osteoporosis. The FDA officially approves Boniva only for treatment of postmenopausal women, as the clinical studies that led to approval mostly enrolled women.